@FierceMedDev: Medtronic's latest study attempts to convince you that CRT-Ds are a bargain. More | Follow @FierceMedDev
> Roche is developing a companion diagnostic for its schizophrenia drug, the company's head of neuroscience told Bloomberg. Story
> U-Systems has received a PMA approvable letter from the FDA regarding the company's new automated breast ultrasound system. Release
> Investors are eyeing companies such as OPKO Health, Forbes asserts, which is developing a blood-based diagnostic test for Alzheimer's disease and plans to launch a diagnostic screening system for prostate cancer in Europe later this year. Story
> iRhythm's Zio Patch, a small adhesive bandage that can continuously monitor a patient's heart rhythm for about two weeks, has shown promise in a clinical study conducted by Scripps Health physicians and others. Release
> Curetis AG, a molecular diagnostics company based in Germany, gained a CE mark for its Unyvero instruments and P50 pneumonia diagnostics cartridge. Both products are rolling out commercially. Release
> SQI Diagnostics in Toronto has closed a private placement funding round designed to support further development of its IVD autoimmune test panels. Release
> Angel Biotechnology Holdings has acquired the assets of a biomaterial and collagen manufacturing business. Release
Pharma News
@FiercePharma: Merck Serono workers threaten to strike in opposition to Geneva HQ closure. Already, protestors have hit the streets. | Follow @FiercePharma
> Eisai broadens marketing deal for Arena's weight-loss drug. Story
> Sales-needy Takeda springs for emerging markets growth. Article
> Servier, founder face trial on Mediator charges. News
Biotech News
@FierceBiotech: FDA panel gave Gilead's key HIV drug Quad the OK on Friday. More | Follow @FierceBiotech
@RyanMFierce: Category: Things CROs are good at. Wrong answer: Patient recruitment for clinical trials. Article | Follow @RyanMFierce
@JohnCFierce: Come back from vacation to find lorcaserin looking pretty good for an approval. But how much could Arena really make from it? | Follow @JohnCFierce
> OncoMed offers $115M IPO bet on cancer stem cell work. Article
> Cancer drug developers angling for center stage at ASCO. More
> Big Pharma's high-risk pursuit of CNS gold faces major market doubts. Story
Biotech IT News
> BioClinica chief touts Microsoft ties in Q1 report. News
> Boehringer, pharmas turn to social gaming for online outreach. Article
> Roche unit allies with genomics software group SoftGenetics. More
And Finally... Medical device inventors and entrepreneurs Dean Kamen and Thomas Fogarty will take part in a panel discussion focused on the future of the industry on May 23 at the Medical Design and Manufacturing East conference in Philadelphia, at the Pennsylvania Convention Center. Release